Keyphrases
Prognostic Significance
100%
Endometrioid Endometrial Cancer
100%
POLE Exonuclease Domain mutations
100%
POLE mutation
100%
Confidence Interval
22%
Tumor
22%
Adjusted Hazard Ratio
22%
Decreased Risk
22%
Mutation Status
22%
Recurrence Risk
22%
Risk of Death
22%
No Significant Difference
11%
Low Risk
11%
Cox Proportional Hazards Model
11%
Clinical Application
11%
Cancer Patients
11%
Adjuvant Therapy
11%
Improved Survival
11%
Prognostic Marker
11%
Early Disease
11%
Combined Analysis
11%
Survival Outcomes
11%
High Variability
11%
Polymerase Chain Reaction Amplification
11%
Sanger Sequencing
11%
Analysis Support
11%
Treatment of Women
11%
Tumor mutation Burden
11%
Medicine and Dentistry
Recurrent Disease
100%
Exonuclease
100%
Uterine Cancer
100%
Neoplasm
60%
Hazard Ratio
40%
Prevalence
20%
Proportional Hazards Model
20%
Adjuvant Therapy
20%
Sanger Sequencing
20%
Polymerase Chain Reaction
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Endometrium Cancer
100%
Exonuclease
100%
Neoplasm
60%
Prevalence
20%
Diseases
20%